查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318684

神經疼痛治療市場：治療方法、適應症和分銷管道分類 - 全球預測 2023-2030 年

Neuralgia Treatment Market by Treatment, Indication, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2023 年，全球神經痛治療市場將達到 106895 萬美元，年複合成長率為 12.39%，預計到 2030 年將以 242577 萬美元的驚人速度成長。

FPNV定位矩陣

FPNV定位矩陣對於評估全球神經痛治療市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.神經痛治療的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球神經疼痛治療市場的阻礙因素和影響為何？

3.在預測期內，全球神經痛治療市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球神經痛治療市場的競爭策略是什麼？

5. 全球神經痛治療市場的技術趨勢和法律規範是什麼？

6.全球神經疼痛治療市場主要廠商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球神經痛治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 隨著高齡化，神經痛日益嚴重
      • 政府努力提高人們對神經疼痛治療產品的認知
    • 抑制因素
      • 治療神經痛費用昂貴
    • 機會
      • 技術進步將消除對藥物和手術的需求
      • 新興經濟體外科和藥物療法的發展
    • 任務
      • 藥物的持續副作用
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化
    • 法律規範

第6章 依治療方式分類的神經痛治療市場

  • 基於藥物的
    • 抗驚厥藥
    • 三環抗憂鬱藥
  • 外科手術
    • 球囊壓縮
    • 甘油注射液
    • 微血管減壓手術
    • 射頻熱損傷
    • 立體定位放射線手術

第7章 神經痛治療市場（按適應症）

  • 糖尿病神經病變
  • 肋間神經痛
  • 枕神經痛
  • 週邊神經痛
  • 帶狀皰疹後遺症神經痛
  • 三叉神經痛

第8章 神經痛治療市場：按分銷管道

  • 藥局
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 美洲神經痛治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太神經痛治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲神經痛治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-F74E250AD649

The Global Neuralgia Treatment Market is forecasted to grow significantly, with a projected USD 1,068.95 million in 2023 at a CAGR of 12.39% and expected to reach a staggering USD 2,425.77 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neuralgia Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neuralgia Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Drug-Based and Surgery. The Drug-Based is further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery is further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery. The Drug-Based is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia. The Intercostal Neuralgia is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neuralgia Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuralgia Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuralgia Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuralgia Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Neuralgia Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Neuralgia Treatment Market?

6. What is the market share of the leading vendors in the Global Neuralgia Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Neuralgia Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neuralgia Treatment Market, by Treatment, 2022 vs 2030
  • 4.3. Neuralgia Treatment Market, by Indication, 2022 vs 2030
  • 4.4. Neuralgia Treatment Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Neuralgia Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
      • 5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost associated with the treatment of neuralgia
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement eliminates the need for drugs and surgery
      • 5.1.3.2. Developing surgical and pharmacological treatment in developing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Persistent side effects from medications
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Regulatory Framework

6. Neuralgia Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Drug-Based
    • 6.2.1. Anticonvulsant Medicines
    • 6.2.2. Tricyclic Antidepressants
  • 6.3. Surgery
    • 6.3.1. Balloon Compression
    • 6.3.2. Glycerol Injection
    • 6.3.3. Microvascular Decompression
    • 6.3.4. Radiofrequency Thermal Lesioning
    • 6.3.5. Stereotactic Radiosurgery

7. Neuralgia Treatment Market, by Indication

  • 7.1. Introduction
  • 7.2. Diabetic Neuropathy
  • 7.3. Intercostal Neuralgia
  • 7.4. Occipital Neuralgia
  • 7.5. Peripheral Neuralgia
  • 7.6. Postherpetic Neuralgia
  • 7.7. Trigeminal Neuralgia

8. Neuralgia Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Neuralgia Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neuralgia Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neuralgia Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEURALGIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NEURALGIA TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
  • FIGURE 5. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. NEURALGIA TREATMENT MARKET DYNAMICS
  • FIGURE 9. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NEURALGIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 5. NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 6. NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 10. NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 238. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 239. NEURALGIA TREATMENT MARKET LICENSE & PRICING